Boudewijn L DeJonge

2.4k total citations
11 papers, 393 citations indexed

About

Boudewijn L DeJonge is a scholar working on Molecular Medicine, Pharmacology and Molecular Biology. According to data from OpenAlex, Boudewijn L DeJonge has authored 11 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Medicine, 5 papers in Pharmacology and 3 papers in Molecular Biology. Recurrent topics in Boudewijn L DeJonge's work include Antibiotic Resistance in Bacteria (10 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Cancer therapeutics and mechanisms (2 papers). Boudewijn L DeJonge is often cited by papers focused on Antibiotic Resistance in Bacteria (10 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Cancer therapeutics and mechanisms (2 papers). Boudewijn L DeJonge collaborates with scholars based in United States, Japan and United Kingdom. Boudewijn L DeJonge's co-authors include Robert S. Daum, Beatriz Meurer Moreira, Susan Boyle‐Vavra, David E. Ehmann, Michael D. Huband, R.A. Giacobbe, Alita A. Miller, Robert E. McLaughlin, William F. Penwell and Rong-Fang Gu and has published in prestigious journals such as Journal of Clinical Microbiology, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Boudewijn L DeJonge

11 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Boudewijn L DeJonge United States 5 225 144 143 132 80 11 393
James Whiteaker United States 7 329 1.5× 125 0.9× 249 1.7× 92 0.7× 86 1.1× 10 550
Diixa Patel United States 7 209 0.9× 81 0.6× 209 1.5× 179 1.4× 57 0.7× 7 435
M. Megan Lemmon United States 9 159 0.7× 52 0.4× 135 0.9× 138 1.0× 39 0.5× 12 347
Elizabeth Gradelski United States 13 260 1.2× 261 1.8× 114 0.8× 135 1.0× 129 1.6× 19 513
Ziad Tarazi United States 10 310 1.4× 218 1.5× 83 0.6× 57 0.4× 138 1.7× 15 429
Martin S. Linsell United States 11 218 1.0× 193 1.3× 254 1.8× 136 1.0× 82 1.0× 11 594
Guillermo Bahr Argentina 10 422 1.9× 119 0.8× 181 1.3× 96 0.7× 110 1.4× 12 533
Denia Frank Germany 9 260 1.2× 128 0.9× 130 0.9× 64 0.5× 90 1.1× 12 355
Kristen N. Schurek Canada 10 251 1.1× 148 1.0× 183 1.3× 50 0.4× 142 1.8× 10 457

Countries citing papers authored by Boudewijn L DeJonge

Since Specialization
Citations

This map shows the geographic impact of Boudewijn L DeJonge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boudewijn L DeJonge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boudewijn L DeJonge more than expected).

Fields of papers citing papers by Boudewijn L DeJonge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boudewijn L DeJonge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boudewijn L DeJonge. The network helps show where Boudewijn L DeJonge may publish in the future.

Co-authorship network of co-authors of Boudewijn L DeJonge

This figure shows the co-authorship network connecting the top 25 collaborators of Boudewijn L DeJonge. A scholar is included among the top collaborators of Boudewijn L DeJonge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boudewijn L DeJonge. Boudewijn L DeJonge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
DeJonge, Boudewijn L, et al.. (2025). The impact of commercially available media on cefiderocol susceptibility testing by broth microdilution method. Journal of Clinical Microbiology. 63(9). e0047125–e0047125. 1 indexed citations
2.
Onishi, Motoyasu, et al.. (2025). P-1099. Correlation Analysis of Cefiderocol In vitro Activity and In vivo Efficacy Against Acinetobacter baumannii Strains with Difficult-to-Read MIC Endpoints. Open Forum Infectious Diseases. 12(Supplement_1). 1 indexed citations
3.
4.
Vila‐Farrés, Xavier, Jun Kyun Oh, Steven M. Swift, et al.. (2023). Rapid bacteriolysis of Staphylococcus aureus by lysin exebacase. Microbiology Spectrum. 11(5). e0190623–e0190623. 4 indexed citations
5.
DeJonge, Boudewijn L, Sean Nguyen, Joshua Maher, et al.. (2023). 2761. Activity of Cefiderocol and Comparator Agents Against Achromobacter and Burkholderia Isolates, Collected During 2020-2022 as Part of SENTRY Antimicrobial Surveillance Program. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations
6.
Giacobbe, R.A., Michael D. Huband, Boudewijn L DeJonge, & Patricia A. Bradford. (2016). Effect of Susceptibility Testing Conditions on the In Vitro Antibacterial Activity of ETX0914. Diagnostic Microbiology and Infectious Disease. 87(2). 139–142. 5 indexed citations
7.
McLeod, Sarah M., Adam B. Shapiro, Samir H. Moussa, et al.. (2016). Sulbactam Combined With the Novel β-lactamase Inhibitor ETX2514 for the Treatment of Multidrug-Resistant Acinetobacter baumannii Infections. Open Forum Infectious Diseases. 3(suppl_1). 2 indexed citations
8.
9.
Penwell, William F., Adam B. Shapiro, R.A. Giacobbe, et al.. (2015). Molecular Mechanisms of Sulbactam Antibacterial Activity and Resistance Determinants in Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy. 59(3). 1680–1689. 183 indexed citations
10.
Reck, Folkert, Richard A. Alm, Patrick Brassil, et al.. (2011). Novel N-Linked Aminopiperidine Inhibitors of Bacterial Topoisomerase Type II: Broad-Spectrum Antibacterial Agents with Reduced hERG Activity. Journal of Medicinal Chemistry. 54(22). 7834–7847. 86 indexed citations
11.
Moreira, Beatriz Meurer, Susan Boyle‐Vavra, Boudewijn L DeJonge, & Robert S. Daum. (1997). Increased production of penicillin-binding protein 2, increased detection of other penicillin-binding proteins, and decreased coagulase activity associated with glycopeptide resistance in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 41(8). 1788–1793. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James Whiteaker Breakdown of academic impact, for papers by Diixa Patel Breakdown of academic impact, for papers by M. Megan Lemmon Breakdown of academic impact, for papers by Elizabeth Gradelski Breakdown of academic impact, for papers by Ziad Tarazi Breakdown of academic impact, for papers by Martin S. Linsell Breakdown of academic impact, for papers by Guillermo Bahr Breakdown of academic impact, for papers by Denia Frank Breakdown of academic impact, for papers by Kristen N. Schurek
Rankless by CCL
2026